<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>BELEODAQ (belinostat) for injection - for Healthcare Professionals (HCPs)</title>
    <meta name="description" content="In the next round against relapsed or refractory PTCL, fight on with BELEODAQ. It is an HDAC inhibitor available for relapsed/refractory PTCL.">
    <!-- Favicon -->
    <link rel="icon" href="https://beleodaq.com/hcp/wp-content/uploads/2019/05/cropped-favicon-Beleodaq-32x32.png" sizes="32x32">
    <!-- Google fonts -->
    <link rel="preconnect" href="https://fonts.gstatic.com">
    <link href="https://fonts.googleapis.com/css2?family=Open+Sans:wght@300;400;600;700;800&family=Raleway:wght@700&display=swap" rel="stylesheet">
    <!-- Font Awesome CDN -->
    <script src="https://kit.fontawesome.com/2d2e2839ee.js" crossorigin="anonymous"></script>
    <!-- CSS Reset -->
    <link rel="stylesheet" href="css/reset.css">
    <!-- Stylesheet -->
    <link rel="stylesheet" href="css/index.css">
</head>
<body>
    <!-- Header -->
    <header class="header">
        <!-- Indications and Usage -->
        <div class="indications">
            <h5 class="indications__title">Indications and Usage</h5>
            <p class="indications__body copyright">BELEODAQ is a histone deacetylase inhibitor indicated for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). This indication is approved under accelerated approval based on tumor response rate and duration of response. An improvement in survival or disease-related symptoms has not been established. Continued approval for this indication may be contingent upon veriﬁcation and description of clinical beneﬁt in the conﬁrmatory trial.<sup>1</sup></p>
        </div>
        <!-- Navigation -->
        <nav class="nav">
            <!-- Logo -->
            <a class="nav__logo" href="index.html">
                <img src="assets/svg/beleodaq-logo.svg" alt="BELEODAQ® (belinostat) for injection: For injection in the treatment of relapsed or refractory PTCL" />
            </a>
            <!-- Header Buttons -->
            <div class="nav__buttons">
                <!-- Site Buttons (redirecting to other parts of site) -->
                <ul class="site-buttons">
                    <li>
                        <a class="site-buttons__button p" href="#">
                            Important Safety Information
                        </a>
                    </li>
                    <li>
                        <a class="site-buttons__button p"
                        href="#">
                           Prescribing Information
                        </a>
                    </li>
                    <li>
                        <a class="site-buttons__button button--orange p" href="#">
                           Patient Site
                        </a>
                    </li>
                </ul>
                <!-- Mobile Logo -->
                <a class="mobile__logo" href="index.html">
                    <img src="assets/svg/beleodaq-logo.svg" alt="BELEODAQ® (belinostat) for injection: For injection in the treatment of relapsed or refractory PTCL" />
                </a>
                <!-- Nav Links and Dropdown Menus -->
                <button class="mobile__button">
                    <img src="assets/svg/menu/bars.svg" alt="hamburger menu button" class="mobile__button__icon"/>
                </button>
                <ul class="navlinks">
                    <li>
                        <a class="navlinks__link p" href="ptcl.html">PTCL <br>Overview</a>
                    </li>
                    <li>
                        <a class="navlinks__link p" href="about.html">About <br>Beleodaq</a>
                    </li>
                    <li>
                        <a class="navlinks__link p" href="inclusion-criteria.html">BELIEF <br>Trial</a>
                    </li>
                    <li>
                        <a class="navlinks__link p" href="efficacy.html"><br>Efficacy</a>
                        <ul class="dropdown dropdown--hidden">
                            <li>
                                <a href="" class="dropdown__item p">
                                    Study design
                                </a>
                            </li>
                            <li>
                                <a href="" class="dropdown__item p">
                                    Baseline Characteristics
                                </a>
                            </li>
                            <li>
                                <a href="" class="dropdown__item p">
                                    Response Rate
                                </a>
                             </li>
                            <li>
                                <a href="" class="dropdown__item p">
                                    Duration of Response
                                </a>
                            </li>
                        </ul>
                    </li>
                    <li>
                        <a class="navlinks__link p" href="safety.html">Safety & Tolerability</a>
                        <ul class="dropdown dropdown--hidden">
                            <li>
                                <a href="" class="dropdown__item p">
                                    Adverse Reactions
                                </a>
                            </li>
                            <li>
                                <a href="" class="dropdown__item p">
                                    Tolerability
                                </a>
                            </li>
                        </ul>
                    </li>
                    <li>
                        <a class="navlinks__link p" href="dosing.html">Dosing & Administration</a>
                        <ul class="dropdown dropdown--hidden">
                            <li>
                                <a href="" class="dropdown__item p">
                                    Dosing Schedule
                                </a>
                            </li>
                            <li>
                                <a href="" class="dropdown__item p">
                                    Dose Modifications
                                </a>
                            </li>
                        </ul>
                    </li>
                    <li>
                        <a class="navlinks__link p" href="access.html">Access & Resources</a>
                        <ul class="dropdown dropdown--hidden">
                            <li>
                                <a href="" class="dropdown__item p">
                                    STAR
                                </a>
                            </li>
                            <li>
                                <a href="" class="dropdown__item p">
                                    Resources
                                </a>
                            </li>
                        </ul>
                    </li>
                    <li>
                        <a class="navlinks__link p" href="contact.html">Contact <br>Us</a>
                    </li>
                </ul>
            </div>
        </nav>
    </header>
    <!-- Main -->
    <main>
        <h2 class="primary">Privacy Policy</h2>
        <p class="semibold dark">ACROTECH BIOPHARMA, LLC and its subsidiaries is committed to protecting the privacy and security of your information. The protection of your privacy in the processing of your personal data is an important concern to which we pay special attention during our business processes. We process personal data collected during visits to our websites according to the legal provisions valid for the countries in which the websites are maintained. This privacy notice describes the information about you that ACROTECH collects through this site, how that information is used, maintained, shared, protected and how you can update it. It also applies to all personal data received by ACROTECH from the European Economic Area (“EEA”) in any format, including electronic or paper. It is effective on the date posted below and applies to our use of your information after that date.</p>
        <p class="dark light">
        <span class="secondary-variant semibold">Personal data we collect about you<br></span>
        We collect personal data from you, for example, if you register for an event, request information, product or use our services, or request customer support. We may ask you to provide information such as your name, address, zip code, phone number, email address, job title, IP Address, and information about your device. Not all of the personal data ACROTECH holds about you, will always come directly from you. It may, for example, come from your employer, other organizations to which you belong, or a professional service provider such as your tax or accounting professional or attorney, if they use our Services. However, ACROTECH collects Personal data about you when you interact with this site and/or utilize services offered on this site.</p>

        <p class="dark light">
            For example:<br>
            If you apply for a job or other staffing opportunity through this site, you will be asked to submit your resume and as well as other contact information such as your email address, phone number and mailing address. We will use this information to consider you for the job opening that you specify. We may also use this information to contact you regarding other staffing opportunities, both opportunities advertised on this site.
        </p>
        <p class="dark light">
            We may use a third party service provider to assist us with some features of our site. Our service provider will receive your information on our behalf and will not be permitted to use it for any other purpose.

        </p>
        <p class="dark light">
            We may also ask you for personal data in connection with other interactions you have with this Site, including when you answer a survey and when you report a problem with this site or services offered on this site.
        </p>
        <p class="dark light">
            We may also collect personal information from third parties such as our partners, service providers, and publicly available websites, to offer services we think may be of interest and to help us maintain data accuracy, provide, and enhance the services.
        </p>
        <p class="dark light">
            We may also collect special categories of personal data such as information concerning health when you report a problem with this site or services offered by us.
        </p>
        <p class="dark light">
            <span class="semibold secondary-variant">How we use your personal data<br></span>
            We can only use your personal data if we have a proper reason for doing so. According to the law, we can only use your data for one or more of these reasons:
        </p>
            <ul>
                <li class="pp">
                    <p class="light dark">
                    To fulfil a contract we have with you, or
                    </p>
                </li>
                <li class="pp">
                    <p class="light dark">
                        If we have a legal duty to use your data for a particular reason, or
                    </p>
                </li>
                <li class="pp">
                    <p class="light dark">
                        When you consent to it, or
                    </p>
                </li>
                <li class="pp">
                    <p class="light dark">
                        When it is in our legitimate interests.
                    </p>
                </li>
            </ul>
            <p class="dark light">
                Legitimate interests are our business or commercial reasons for using your data, but even so, we will not unfairly put our legitimate interests above what is best for you.
            </p>
            <p class="dark light">The use of your information is subject to the privacy notice in effect at the time of our use. Acrotech uses information provided to us for our general business use. This may include the following purposes:</p>
            <ul>
                <li class="pp">
                    <p class="light dark">To respond to your requests;</p>
                </li>
                <li class="pp">
                    <p class="light dark">To provide services to you including customer services issues;</p>
                </li>
                <li class="pp">
                    <p class="light dark">To send communications to you about our or our affiliates’ current services, new services or promotions that we are developing, and opportunities that may be available to you;</p>
                </li>
                <li class="pp">
                    <p class="light dark">To alert you to new features or enhancements to our services;</p>
                </li>
                <li class="pp">
                    <p class="light dark">To communicate with you about job or career opportunities about which you have inquired;</p>
                </li>
                <li class="pp">
                    <p class="light dark">To ensure that our site and our services function in an effective manner for you;</p>
                </li>
                <li class="pp">
                    <p class="light dark">To measure or understand the effectiveness of advertising and outreach.</p>
                </li>
                <li class="pp">
                    <p class="light dark">Marketing and events: We use personal information to deliver marketing and event communications to you across various platforms, such as email, telephone, text messaging, direct mail, and online. If we send you a marketing email, it will include instructions on how to opt out of receiving these emails in the future. We also maintain email preference centers for you to manage your information and marketing preferences. Please remember that even if you opt out of receiving marketing emails, we may still send you important Service information related to your accounts and subscriptions.</p>
                </li>
                <li class="pp">
                    <p class="light dark">Legal obligations: We may be required to use and retain personal information for legal and compliance reasons, such as the prevention, detection, or investigation of a crime; loss prevention; or fraud. We may also use personal information to meet our internal and external audit requirements, information security purposes, and as we otherwise believe to be necessary or appropriate:</p>
                </li>
                <li class="pp">
                    <p class="light dark">Under applicable law, which may include laws outside your country of residence;</p>
                </li>
                <li class="pp">
                    <p class="light dark">To respond to requests from courts, law enforcement agencies, regulatory agencies, and other public and government authorities, which may include such authorities outside your country of residence;</p>
                </li>
            </ul>
            <p class="light dark">We endeavor to collect only such information that is reasonably necessary to perform services for you or to respond to your inquiries.<br>
            You are responsible for ensuring that the information you provide is accurate, complete and current; we will take reasonable steps to ensure that the information we collect and use is relevant to its intended use.</p>
            <p class="light dark">
            <span class="semibold secondary-variant">
                When we share personal data<br>
            </span>
            ACROTECH shares or discloses personal data when necessary to provide services or conduct our business operations.
            ACROTECH may, with your consent, disclose information about you to unaffiliated third-party customers of ACROTECH in connection with your application for staffing opportunities advertised on this site, or in connection with opportunities advertised on a website of one of our affiliates. For example-</p>
            <ul>
                <li class="pp">
                    <p class="light dark">
                        Within ACROTECH: Our businesses around the world are supported by a variety of ACROTECH teams and functions, and personal information will be made available to them if necessary for the provision of Services, account administration, sales and marketing, customer and technical support, and business and product development, for instance. All of our employees and contractors are required to follow our data protection and security policies when handling personal data. Please click here to see a list of ACROTECH locations where we may process personal data
                    </p>
                </li>
                <li class="pp">
                    <p class="light dark">
                        Our business partners: We occasionally collaborate with other organizations to deliver co-branded Services, provide content, or to host events, conferences, and seminars. As part of these arrangements, you may be a customer of both ACROTECH and our partners, and our partners and we may collect and share information about you. ACROTECH will handle personal data in accordance with the privacy notice.
                    </p>
                </li>
            </ul>
            <p class="dark light">
                <span class="secondary-variant semibold">Our third-party service providers:<br></span>
                We collaborate with and are supported by service providers around the world. Personal data will be made available to these parties only when necessary to fulfil the services they provide to us, such as software, system, and platform support; direct marketing services; cloud hosting services; advertising; and order fulfilment and delivery. Our third-party service providers are not permitted to share or use personal data we make available to them for any other purpose than to provide services to us.
            </p>
            <ul>
                <li class="pp">
                    <p class="light dark">
                        Third parties for legal reasons: We will share personal data when we believe it is required, such as:
                        To comply with legal obligations and respond to requests from government agencies, including law enforcement and other public authorities, which may include such authorities outside your country of residence.
                    </p>
                </li>
                <li class="pp">
                    <p class="light dark">
                        In the event of a merger, sale, restructure, acquisition, joint venture, assignment, transfer, or other disposition of all or any portion of our business, assets, or stock (including in connection with any bankruptcy or similar proceedings)
                    </p>
                </li>
                <li class="pp">
                    <p class="light dark">
                        To protect our rights, users, systems, and Services.
                    </p>
                </li>
            </ul>
            <p class="dark light">
                <span class="secondary-variant semibold">Where we store and process personal data<br></span>
                ACROTECH is a global organization, and your personal data may be stored and processed outside. We take steps to ensure that the information we collect is processed according to this Privacy notice and the requirements of applicable law wherever the data is located. ACROTECH has networks, databases, servers, systems, support, and help desks located throughout our offices around the world. We collaborate with third parties such as cloud hosting services, suppliers, and technology support located around the world to serve the needs of our business, workforce, and customers. We take appropriate steps to ensure that personal data is processed, secured, and transferred according to applicable law. In some cases, we may need to disclose or transfer your personal data within ACROTECH or to third parties.<br>
                When we transfer personal information from the European Economic Area to other countries in which applicable laws do not offer the same level of data privacy protection as in your home country, we take measures to provide an appropriate level of data privacy protection. In other words, your rights and protections remain with your data. For example, we use approved contractual clauses, multiparty data transfer agreements, intragroup agreements, and other measures designed to ensure that the recipients of your personal information protect it.
            </p>
            <p class="dark light">
                <span class="secondary-variant semibold">How we secure personal data<br></span>
                ACROTECH takes data security seriously, and we use appropriate technologies and procedures to protect personal information. Our information security policies and procedures are closely aligned with widely accepted international standards and are reviewed regularly and updated as necessary to meet our business needs, changes in technology, and regulatory requirements
            </p>
            <p class="dark light">
                For example:
            </p>
            <ul>
                <li class="pp">
                    <p class="light dark">
                        Policies and procedures: ACROTECH employs reasonable technological, physical and operational security procedures intended to protect your Personal data from loss, misuse, alteration, or unintentional destruction. Our security measures are periodically reviewed and updated in an effort to provide appropriate security for all the data collected about you through this Site.
                    </p>
                </li>
                <li class="pp">
                    <p class="light dark">
                        We place appropriate restrictions on access to personal data
                    </p>
                </li>
                <li class="pp">
                    <p class="light dark">
                        We implement appropriate measures and controls, including monitoring and physical measures, to store and transfer data securely
                    </p>
                </li>
                <li class="pp">
                    <p class="light dark">
                        Training for employees and contractors
                    </p>
                </li>
                <li class="pp">
                    <p class="light dark">
                        We require privacy, information security, and other applicable training on a regular basis for our employees and contractors who have access to personal data and other sensitive data
                    </p>
                </li>
                <li class="pp">
                    <p class="light dark">
                        We take steps to ensure that our employees and contractors operate in accordance with our information security policies and procedures and any applicable contractual conditions.
                    </p>
                </li>
                <li class="pp">
                    <p class="light dark">
                        We require, with contracts and security reviews, our third-party vendors and providers to protect any personal data with which they are entrusted in accordance with our security policies and procedures.
                    </p>
                </li>
            </ul>
            <p class="dark light">
                <span class="secondary-variant semibold">Cookies<br></span>
                From time to time, we may, like many other commercial websites, use a standard technology called a “cookie”. A cookie is a small text file that is placed on a computer or other device and is used to identify the user or device and to collect information. Cookies are typically assigned to one of four categories, depending on their function and intended purpose: necessary cookies, performance cookies, functional cookies, and cookies for marketing purposes. A cookie cannot retrieve any other data from your hard drive, pass on computer viruses, or capture your e-mail address. Currently, websites use cookies to enhance the user’s visit; in general, cookies can securely store a user’s ID and password, personalize home pages, and identify which parts of a site have been visited. It is possible to set your browser to inform you when a cookie is being placed. This way you have the opportunity to decide whether to accept the cookie. By showing how and when our visitors use this Web site, this information can help us to improve our site on a continual basis.
            </p>
            <p class="dark light">
                <span class="secondary-variant semibold">Children<br></span>
                This site is not intended to collect or maintain personal data from persons under 13 years old. IF YOU ARE UNDER 13 YEARS OF AGE, PLEASE DO NOT USE OR ACCESS THIS SITE. If ACROTECH learns that personally identifiable information of a person under 13 years old has been collected without verifiable parental consent, then ACROTECH will take the appropriate steps to delete such information.
            </p>
            <p class="dark light">
                <span class="secondary-variant semibold">Your rights and your personal data<br></span>
                We respect your right to access and control your information, and we will respond to requests for information and, where applicable, will correct, amend, or delete your personal information.
            </p>
            <p class="dark light">In such cases, we will need you to respond with proof of your identity before you can exercise these rights.</p>
            <ul>
                <li class="pp">
                    <p class="light dark">
                        The right to access information: At any point you can contact us to request the information we hold on you as well as why we have that information, who has access to the information and where we obtained the information from. Once we have received your request we will respond within one month.
                    </p>
                </li>
                <li class="pp">
                    <p class="light dark">
                        There are no fees or charges for the first request but additional requests for the same data may be subject to an administrative fee.
                    </p>
                </li>
                <li class="pp">
                    <p class="light dark">
                        The right to correct and update the information: If the data we hold on you is out of date, incomplete or incorrect, you can inform us and your data will be updated.
                    </p>
                </li>
                <li class="pp">
                    <p class="light dark">
                        The right to have your information erased: If you feel that we should no longer be using your data or that we are illegally using your data, you can request that we erase the data we hold. When we receive your request we will confirm whether the data has been deleted or the reason why it cannot be deleted (for example because we need it for our legitimate interests or regulatory purpose(s).
                    </p>
                </li>
                <li class="pp">
                    <p class="light dark">
                        The right to object to processing: You have the right to request that we stop processing your data. Upon receiving the request, we will contact you and let you know if we are able to comply or if we have legitimate grounds to continue to process your data. Even after you exercise your right to object, we may continue to hold your data to comply with your other rights or to bring or defend legal claims.
                    </p>
                </li>
                <li class="pp">
                    <p class="light dark">
                        The right to data portability: You have the right to request that we transfer some of your data to another controller. We will comply with your request, where it is feasible to do so, within one month of receiving your request.
                    </p>
                </li>
                <li class="pp">
                    <p class="light dark">
                        The right to withdraw your consent: to the processing at any time for any processing of data to which consent was sought. You can withdraw your consent easily by telephone, email, or by post (see Contact Details below).
                    </p>
                </li>
                <li class="pp">
                    <p class="light dark">
                        The right to object to the processing: of personal data where applicable.
                    </p>
                </li>
                <li class="pp">
                    <p class="light dark">
                        The right to lodge a complaint: with the Data Protection officer at dpo@aurobindo.com
                    </p>
                </li>
            </ul>
            <p class="dark light">
                <span class="secondary-variant semibold">How long do we keep your personal data?<br></span>
                We retain personal information for as long as we reasonably require it for legal or business purposes. In determining data retention periods, ACROTECH takes into consideration local laws, contractual obligations, and the expectations and requirements of our customers. When we no longer need personal information, we securely delete or destroy it.
            </p>
            <p class="secondary-variant semibold">Changes to Our Privacy notice</p>
            <p class="dark light">
                ACROTECH BIOPHARMA may update privacy notice from time to time. We encourage you to check our site frequently to see the current privacy notice so that you may stay informed of how ACROTECH is using and protecting your information. Whenever a change to this notice is significant, we will place a prominent notice on this site and provided an updated effective date.
            </p>
            <p class="secondary-variant semibold">Questions/Contact Information</p>
            <p class="dark light">If you have questions or comments regarding this privacy notice, please contact us, or at:
            </p>
            <p class="dark light">
                Acrotech Biopharma, LLC<br>
                Address: 279 Princeton Hightstown Rd., East Windsor, NJ 08520<br>
                Phone: (866) 850-2876<br>
                Email: info@AcrotechBiopharma.com<br>
                Effective Date: April 11, 2019<br>
            </p>
            
    </main>
    <!-- ISI -->
    <footer>
        <section class="isi">
            <div>
                <h5 class="isi__header">Select Important Safety Information</h5>
                <p class="isi__body light"><span class="isi__body--bold ">Warnings and Precautions</span>
                BELEODAQ can cause thrombocytopenia, leukopenia (neutropenia and lymphopenia), and/or anemia; monitor blood counts weekly during treatment, and modify dosage as necessary.</p>
            </div>
            <a class="isi__button more" onclick="scrollToFooter()" href="javascript:;">
                See More <i class="fas fa-arrow-down"></i>
            </a>
            <a class="isi__button less hidden" onclick="scrollBack()" href="javascript:;">
                See Less <i class="fas fa-arrow-up"></i>
            </a>
        </section>
        <section class="hidden">
            <h5 class="primary">Indications and Usage</h5>
            <ul>
                <li>
                    <p class="light">BELEODAQ is a HDAC inhibitor indicated for the treatment of patients with R/R PTCL</p>
                </li>
                <li>
                    <p class="light">This indication is approved under accelerated approval based on tumor response rate and DoR. An improvement in survival or disease-related symptoms has not been established. Continued approval for this indication may be contingent upon verification and description of clinical benefit in the confirmatory trial.
                    </p>
                </li>
            </ul>
            <div class="warnings-and-precautions">
                <h5 class="primary">Warnings and Precautions</h5>
                <p class="light"><span class="semibold">Hematologic Toxicity:</span> BELEODAQ can cause thrombocytopenia, leukopenia (neutropenia and lymphopenia), and/or anemia; monitor blood counts weekly during treatment and modify dosage as necessary.</p>
                <p class="light"><span class="semibold">Infections:</span> Serious and sometimes fatal infections, including pneumonia and sepsis, have occurred with BELEODAQ. Do not administer BELEODAQ to patients with an active infection. Patients with a history of extensive or intensive chemotherapy may be at a higher risk of life-threatening infections.</p>
                <p class="light"><span class="semibold">Hepatotoxicity:</span> BELEODAQ can cause fatal hepatotoxicity and liver function test abnormalities. Monitor liver function tests before treatment and before the start of each cycle. Interrupt or adjust dosage until recovery, or permanently discontinue BELEODAQ based on the severity of the hepatic toxicity.</p>
                <p class="light"><span class="semibold">Tumor Lysis Syndrome:</span> Tumor lysis syndrome has occurred in BELEODAQ-treated patients in the clinical trial of patients with relapsed or refractory PTCL. Monitor patients with advanced stage disease and/or high tumor burden, and take appropriate precautions.</p>
                <p class="light"><span class="semibold">Gastrointestinal Toxicity:</span> Nausea, vomiting, and diarrhea occur with BELEODAQ and may require the use of antiemetic and antidiarrheal medications.</p>
                <p class="light"><span class="semibold">Embryo-Fetal Toxicity:</span> BELEODAQ can cause fetal harm when administered to a pregnant woman. Advise pregnant women of the risk to a fetus. Advise females of reproductive potential to use an effective method of contraception during treatment with BELEODAQ and for 6 months after the last dose. Advise males with female partners of reproductive potential to use effective contraception during treatment with BELEODAQ and for 3 months after the last dose.</p>
            </div>
            <h5 class="primary">Adverse Reactions</h5>
            <ul>
                <li>
                    <p class="light">The most common adverse reactions observed in more than 25% of patients with relapsed or refractory PTCL in the trial, who were treated with BELEODAQ, were nausea (42%), fatigue (37%), pyrexia (35%), anemia (32%), and vomiting (29%).</p>
                </li>
                <li>
                    <p class="light">Sixty-one patients (47.3%) experienced serious adverse reactions while taking BELEODAQ or within 30 days after their last dose of BELEODAQ. The most common serious adverse reactions (>2%) were pneumonia, pyrexia, infection, anemia, increased creatinine, thrombocytopenia, and multi-organ failure.</p>
                </li>
            </ul>
            <h5 class="primary">Drug Interactions</h5>
            <ul>
                <li>
                    <p class="light">BELEODAQ is primarily metabolized by UGT1A1. Avoid concomitant administration of BELEODAQ with strong inhibitors of UGT1A1.</p>
                </li>
            </ul>
            <div class="specific-populations">
                <h5 class="primary">Use in Specific Populations</h5>
                <p class="light"><span class="semibold">Lactation:</span> Due to the potential for serious adverse reactions in the breastfed child, advise patients that breastfeeding is not recommended during treatment with BELEODAQ and for 2 weeks after the last dose.</p>
                <p class="light"><span class="semibold">Pregnancy Testing:</span> BELEODAQ can cause fetal harm when administered to a pregnant woman. Pregnancy testing is recommended for females of reproductive potential prior to initiating BELEODAQ.</p>
                <p class="light"><span class="semibold">Pediatric Use:</span> The safety and effectiveness of BELEODAQ in pediatric patients have not been established.</p>
            </div>
            <a href="#">
                <p class="semibold">
                Please see full Prescribing Information for BELEODAQ.
                </p>
            </a>
            <p class="light">You are encouraged to report negative side effects of prescription drugs to the FDA. Visit <span class="secondary-variant semibold">www.fda.gov/medwatch</span> or call <span class="secondary-variant semibold">1-800-FDA-1088 (1-800-332-1088)</span>. You also may contact Acrotech Biopharma, LLC at <span class="secondary-variant semibold">1-888-292-9617</span>.</p>
            
            <h5 class="primary">References</h5>
            <p class="light">1. BELEODAQ®[Prescribing Information], AcrotechBiopharma, LLC; January 2020. 2. O’Connor O, et al. J Clin Oncol. 2015;33:2492-2499. 3. Vose JM, et al. J Clin Oncol. 2008;26:4124-4130. 4. Carson KR, et al. Cancer. 2017;123:1174-1183. 5. LansiganF, et al. Acta Haematol. 2020;143:40-50. 6. BelleiM, et al. Haematologica. 2018;103:1191-1197. 7. Li W, et al. Int J Mol Sci. 2019;20. doi:10.3390/ijms20071616. 8. Milazzo G, et al. Genes. 2020;11. doi:10.3390/genes11050556. 9. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for T-Cell Lymphomas V.1.2021. © 2021 National Comprehensive Cancer Network, Inc. All rights reserved. Accessed February 25, 2021. The NCCN Guidelines® and illustrations herein may not be reproduced in any form for any purpose without the express written permission of NCCN. To view the most recent and complete version of the NCCN Guidelines, go online to NCCN.org. The NCCN Guidelines are a work in progress that may be refined as often as new significantdata becomes available. 10. Savage KJ, et al. Blood. 2014:124:3075. doi.org/10.1182/blood.V124.21.3075.3075.</p>
            <div class="footer__bottom">
                <img src="assets/images/acrotech-logo.png" alt="Acrotech Biopharma Logo" />
                <p class="light">
                    © Acrotech Biopharma, LLC. 2019. All rights reserved.<br>
                    Information on this website is intended for U.S. residents.<br>
                    BEL-XXX. June 2021.
                </p>
                <div class="bottom_col">
                    <p class="light">Contact Information U.S.</p>
                    <p class="light">Privacy Policy</p>
                    <p class="light">Linking Policy</p>
                </div>
                <div class="bottom_col">
                    <p class="light">Terms of Use</p>
                    <p class="light">Trademark Policy</p>
                    <p class="light">Full Prescribing Information</p>
                </div>
            </div>
        </section>
    </footer>
    <!-- Vanilla JS -->
    <script src="js/app.js"></script>
</body>
</html>